Status:
COMPLETED
Effect of CYP2C9*3 Polymorphism on Ibuprofen in Pakistani Population
Lead Sponsor:
Riphah International University
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-60 years
Brief Summary
The goal of this Observational study was to identify the effect of CYP2C9 gene polymorphism in the Pakistani population. The main question it aims to answer were: * to evaluate the effect of this gen...
Detailed Description
The goal of this observational study was to identify the effect of CYP2C9\*3 gene polymorphism in the Pakistani population, due to the high prevalence of this variant in the Pakistani Population The ...
Eligibility Criteria
Inclusion
- Pakistani individuals
- Absence of systemic diseases
- Extractions required based on orthodontic, periodontal, and endodontic indications
Exclusion
- history of bleeding or gastrointestinal ulcers
- allergic to ibuprofen or other NSAIDs.
- Pregnancy
Key Trial Info
Start Date :
November 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05983042
Start Date
November 1 2022
End Date
July 31 2023
Last Update
August 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ammarah Amjad
Rawalpindi, Punjab Province, Pakistan, 46000